Genome-wide linkage scan for prostate cancer susceptibility in Finland: Evidence for a novel locus on 2q37.3 and confirmation of signal on 17q21-q22

International Journal of Cancer

Volumn 129, Issue 10, 2011, Pages 2400-2407

  Cropp, Cheryl D ^a   Simpson, Claire L ^a   Wahlfors, Tiina ^b,c   Ha, Nati ^b,c   George, Asha ^a,d   Jones, Marypat S ^a   Harper, Ursula ^a   Ponciano Jackson, Damaris ^a   Green, Tiffany A ^a,e   Tammela, Teuvo L J ^c   Bailey Wilson, Joan ^a   Schleutker, Johanna ^b,c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d FOX CHASE CANCER CENTER   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

17q; 2q; Finland; genome wide linkage; prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME 2; CHROMOSOME 22Q; CHROMOSOME 2Q; CONTROLLED STUDY; ETHNIC GROUP; FAMILY ASSESSMENT; FEMALE; FINLAND; FINNISH; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NONPARAMETRIC TEST; PARAMETRIC TEST; PRIORITY JOURNAL; PROSTATE CANCER; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 2; FINLAND; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICROSATELLITE REPEATS; PROSTATIC NEOPLASMS;

EID: 79960901637     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25906     Document Type: Article

References (47)

1. Finnish Cancer Registry. Cancer incidence and mortality in Finland: Cancer Statistics. Finnish Cancer Registry, Helsinki, Finland, 2007.
2. Schaid DJ,. The complex genetic epidemiology of prostate cancer. Hum Mol Genet 2004; 13 (Spec No. 1): R103-21. (Pubitemid 38443804)
3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K,. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85. (Pubitemid 30451850)
4. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008; 40: 316-21. (Pubitemid 351311772)
5. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008; 40: 310-5. (Pubitemid 351311773)
6. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008; 40: 281-3. (Pubitemid 351311771)
7. Service S, DeYoung J, Karayiorgou M, Roos JL, Pretorious H, Bedoya G, Ospina J, Ruiz-Linares A, Macedo A, Palha JA, Heutink P, Aulchenko Y, et al. Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies. Nat Genet 2006; 38: 556-60.
8. Schleutker J, Baffoe-Bonnie AB, Gillanders E, Kainu T, Jones MP, Freas-Lutz D, Markey C, Gildea D, Riedesel E, Albertus J, Gibbs KD, Jr, Matikainen M, et al. Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26. Prostate 2003; 57: 280-9. (Pubitemid 37487073)
9. Rokman A, Baffoe-Bonnie AB, Gillanders E, Fredriksson H, Autio V, Ikonen T, Gibbs KD, Jr, Jones M, Gildea D, Freas-Lutz D, Markey C, Matikainen MP, et al. Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Hum Genet 2005; 116: 43-50. (Pubitemid 40057915)
10. Boehnke M, Cox NJ,. Accurate inference of relationships in sib-pair linkage studies. Am J Hum Genet 1997; 61: 423-9. (Pubitemid 27382319)
11. Broman KW, Weber JL,. Estimation of pairwise relationships in the presence of genotyping errors. Am J Hum Genet 1998; 63: 1563-4. (Pubitemid 30418557)
12. Wigginton JE, Abecasis GR,. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005; 21: 3445-7. (Pubitemid 41222458)
13. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC,. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75. (Pubitemid 47330214)
14. Barrett JC, Fry B, Maller J, Daly MJ,. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5. (Pubitemid 40202029)
15. Kong A, Cox NJ,. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997; 61: 1179-88. (Pubitemid 27492328)
16. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES,. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347-63. (Pubitemid 26153846)
17. Hastbacka J, de la Chapelle A, Kaitila I, Sistonen P, Weaver A, Lander E,. Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet 1992; 2: 204-11.
18. Lander E, Kruglyak L,. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-7.
19. Hodge SE, Abreu PC, Greenberg DA,. Magnitude of type I error when single-locus linkage analysis is maximized over models: a simulation study. Am J Hum Genet 1997; 60: 217-27. (Pubitemid 26427796)
20. Hodge SE, Rodriguez-Murillo L, Strug LJ, Greenberg DA,. Multipoint lods provide reliable linkage evidence despite unknown limiting distribution: type I error probabilities decrease with sample size for multipoint lods and mods. Genet Epidemiol 2008; 32: 800-15.
21. Strug LJ, Hodge SE,. An alternative foundation for the planning and evaluation of linkage analysis. I. Decoupling "error probabilities" from "measures of evidence." Hum Hered 2006; 61: 166-88. (Pubitemid 44385445)
22. Suarez BK, Lin J, Burmester JK, Broman KW, Weber JL, Banerjee TK, Goddard KA, Witte JS, Elston RC, Catalona WJ,. A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet 2000; 66: 933-44. (Pubitemid 30470495)
23. Pierce BL, Friedrichsen-Karyadi DM, McIntosh L, Deutsch K, Hood L, Ostrander EA, Austin MA, Stanford JL,. Genomic scan of 12 hereditary prostate cancer families having an occurrence of pancreas cancer. Prostate 2007; 67: 410-5. (Pubitemid 46341082)
24. Kiessling A, Weigle B, Fuessel S, Ebner R, Meye A, Rieger MA, Schmitz M, Temme A, Bachmann M, Wirth MP, Rieber EP,. D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family. Prostate 2005; 64: 387-400. (Pubitemid 41193252)
25. Walker MG, Volkmuth W, Sprinzak E, Hodgson D, Klingler T,. Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes. Genome Res 1999; 9: 1198-203. (Pubitemid 30042503)
26. Halkidou K, Cook S, Leung HY, Neal DE, Robson CN,. Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate. Eur Urol 2004; 45: 382-9; author reply 9. (Pubitemid 38221414)
27. De Marchis L, Cropp C, Sheng ZM, Bargo S, Callahan R,. Candidate target genes for loss of heterozygosity on human chromosome 17q21. Br J Cancer 2004; 90: 2384-9. (Pubitemid 38961904)
28. Osborne RJ, Hamshere MG,. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer. Cancer Res 2000; 60: 3706-12. (Pubitemid 32204555)
29. Lange EM, Gillanders EM, Davis CC, Brown WM, Campbell JK, Jones M, Gildea D, Riedesel E, Albertus J, Freas-Lutz D, Markey C, Giri V, et al. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate 2003; 57: 326-34. (Pubitemid 37487078)
30. Lange EM, Robbins CM, Gillanders EM, Zheng SL, Xu J, Wang Y, White KA, Chang BL, Ho LA, Trent JM, Carpten JD, Isaacs WB, et al. Fine-mapping the putative chromosome 17q21-22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis. Hum Genet 2007; 121: 49-55. (Pubitemid 46421140)
31. Lange EM, Beebe-Dimmer JL, Ray AM, Zuhlke KA, Ellis J, Wang Y, Walters S, Cooney KA,. Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23. Prostate 2009; 69: 385-91.
32. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, Kader AK, Turner AR, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008; 358: 910-9. (Pubitemid 351397090)
33. Sun J, Purcell L, Gao Z, Isaacs SD, Wiley KE, Hsu FC, Liu W, Duggan D, Carpten JD, Gronberg H, Xu J, Chang BL, et al. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. Prostate 2008; 68: 691-7. (Pubitemid 351632941)
34. Levin AM, Machiela MJ, Zuhlke KA, Ray AM, Cooney KA, Douglas JA,. Chromosome 17q12 variants contribute to risk of early-onset prostate cancer. Cancer Res 2008; 68: 6492-5.
35. Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K, Figarella-Branger D, Martin PM, Ouafik L,. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells. Oncogene 2008; 27: 506-18.
36. Dhir R, Ni Z, Lou W, DeMiguel F, Grandis JR, Gao AC,. Stat3 activation in prostatic carcinomas. Prostate 2002; 51: 241-6. (Pubitemid 34556374)
37. Yu H, Kortylewski M, Pardoll D,. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007; 7: 41-51. (Pubitemid 46020826)
38. Ballal RD, Saha T, Fan S, Haddad BR, Rosen EM,. BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. J Biol Chem 2009; 284: 36083-98.
39. Agalliu I, Gern R, Leanza S, Burk RD,. Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res 2009; 15: 1112-20.
40. Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, et al. Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate 2010; 70: 735-44.
41. Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, et al. Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet 2007; 16: 1271-8. (Pubitemid 47055123)
42. Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, Erickson HS, Georgevich L, Tangrea MA, Duray PH, Gonzalez S, Velasco A, et al. Molecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res 2005; 11: 6823-34. (Pubitemid 41428737)
43. Fechter A, Buettel I, Kuehnel E, Schwab M, Savelyeva L,. Cloning of genetically tagged chromosome break sequences reveals new fragile sites at 6p21 and 13q22. Int J Cancer 2007; 120: 2359-67. (Pubitemid 46642122)
44. Witte JS, Suarez BK, Thiel B, Lin J, Yu A, Banerjee TK, Burmester JK, Casey G, Catalona WJ,. Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate 2003; 57: 298-308. (Pubitemid 37487075)
45. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA,. Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees. Prostate 2007; 67: 605-13. (Pubitemid 46685280)
46. Stanford JL, FitzGerald LM, McDonnell SK, Carlson EE, McIntosh LM, Deutsch K, Hood L, Ostrander EA, Schaid DJ,. Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage. Hum Mol Genet 2009; 18: 1839-48.
47. Baffoe-Bonnie AB, Smith JR, Stephan DA, Schleutker J, Carpten JD, Kainu T, Gillanders EM, Matikainen M, Teslovich TM, Tammela T, Sood R, Balshem AM, et al. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region. Hum Genet 2005; 117: 307-16. (Pubitemid 41194557)